China belatedly acknowledged the country's exploding HIV-AIDS problem when Premier Wen Jiabao (溫家寶) shook hands with a victim last year, but there is still a long way to go before the deadly virus can be countered.
Arthur Pang (彭偉強), a doctor with humanitarian group Medecins Sans Frontieres and who treated AIDS patients in Hubei Province this year, said expensive drugs and the stigma associated with the disease were still keeping sufferers from the treatment they needed.
"Wen Jiabao may have shaken hands with an AIDS patient, but it will take a long time to get the awareness down to the ground," Pang said in an interview.
Pang, who treated some 150 Chinese patients from last December to last month in an AIDS treatment clinic in Xiangfan City, said Chinese doctors and nurses he worked with had little or no knowledge of the disease.
"At first they donned full gear, like the way they would with SARS patients," Pang said. "Many of them are very scared, they think they may be infected simply by touching."
"Once a patient is confirmed with the disease, they will send the person to an infectious disease hospital, they don't want to touch them. They don't want to deal with AIDS patients," he said.
That attitude began to change at the Xiangfan clinic when staff observed the way Pang worked, and saw that such precautions were unnecessary.
STIGMA AND FEAR
But while attitudes among healthcare workers may be changing, ignorance and fear among the populace is a serious problem.
Those with disease symptoms who suspect they may be infected with HIV do not seek help for fear of being stigmatized by their friends and family, or even sacked by their employers. There is also widespread ignorance that drugs can be used to treat the disease, Pang said.
He recalled a heart-wrenching case of a 29-year-old farmer who could not even stay to have his blood tested because he had to catch the last bus ride home.
The farmer contracted the disease selling blood. He tried to resist being hospitalized for fear nobody would take care of him after his family ran away. He died in hospital in May.
"Some are just too poor, they may even have to borrow money to get to the clinic some three to four hours away from their farms. Sixty or 70 percent of the people who sought treatment at our clinic already had full-blown AIDS," Pang said.
Although China has an estimated 1 million to 1.5 million HIV-AIDS cases, it is ranked alongside India and Russia as countries most at risk from AIDS outside Africa. Health agencies say China could have 10 million victims by 2010 if it fails to take the threat seriously.
Activists hope the world's attention will focus on the epidemic again when experts gather for an international meeting next week in Bangkok.
For years, China has faced international condemnation for disguising the scale of its AIDS epidemic, neglecting patients and arresting activists and journalists.
But last year, Wen became the first Chinese leader to shake hands with an AIDS patient and the government then sent health workers to Henan Province where many villages were hit by botched blood-selling schemes in the 1990s.
Hubei is just south of Henan, where activists estimate that more than 1 million people are infected.
The disease spread there after clinics offered to pay farmers for blood. Plasma was extracted from the donor's blood and then the farmers were reinjected with blood from a pool of donors that was unwittingly infected with the HIV virus.
AIDS treatment is also very expensive in China. The cocktail of three anti-retroviral drugs needed is available only from pharmaceutical giants, which charge huge sums of money for them.
It takes, for example, US$3,800 to treat a patient for a year in China, compared to just US$250 to US$280 in Thailand, where there are lower-cost generic drugs available.
The conflict in the Middle East has been disrupting financial markets, raising concerns about rising inflationary pressures and global economic growth. One market that some investors are particularly worried about has not been heavily covered in the news: the private credit market. Even before the joint US-Israeli attacks on Iran on Feb. 28, global capital markets had faced growing structural pressure — the deteriorating funding conditions in the private credit market. The private credit market is where companies borrow funds directly from nonbank financial institutions such as asset management companies, insurance companies and private lending platforms. Its popularity has risen since
The Donald Trump administration’s approach to China broadly, and to cross-Strait relations in particular, remains a conundrum. The 2025 US National Security Strategy prioritized the defense of Taiwan in a way that surprised some observers of the Trump administration: “Deterring a conflict over Taiwan, ideally by preserving military overmatch, is a priority.” Two months later, Taiwan went entirely unmentioned in the US National Defense Strategy, as did military overmatch vis-a-vis China, giving renewed cause for concern. How to interpret these varying statements remains an open question. In both documents, the Indo-Pacific is listed as a second priority behind homeland defense and
Every analyst watching Iran’s succession crisis is asking who would replace supreme leader Ayatollah Ali Khamenei. Yet, the real question is whether China has learned enough from the Persian Gulf to survive a war over Taiwan. Beijing purchases roughly 90 percent of Iran’s exported crude — some 1.61 million barrels per day last year — and holds a US$400 billion, 25-year cooperation agreement binding it to Tehran’s stability. However, this is not simply the story of a patron protecting an investment. China has spent years engineering a sanctions-evasion architecture that was never really about Iran — it was about Taiwan. The
In an op-ed published in Foreign Affairs on Tuesday, Chinese Nationalist Party (KMT) Chairwoman Cheng Li-wun (鄭麗文) said that Taiwan should not have to choose between aligning with Beijing or Washington, and advocated for cooperation with Beijing under the so-called “1992 consensus” as a form of “strategic ambiguity.” However, Cheng has either misunderstood the geopolitical reality and chosen appeasement, or is trying to fool an international audience with her doublespeak; nonetheless, it risks sending the wrong message to Taiwan’s democratic allies and partners. Cheng stressed that “Taiwan does not have to choose,” as while Beijing and Washington compete, Taiwan is strongest when
RSS